Veradigm issued patent for risk adjustment method and apparatus

Chicago--(business wire)--veradigm, a business unit of allscripts healthcare solutions (nasdaq: mdrx), today announced that its method and apparatus for risk adjustment patent (“dynamic intervention planning”) has been issued by the united states patent and trademark office (uspto). the patent covers the systems that power veradigm's dynamic intervention planning process. these systems enable veradigm's clients to find, size, monetize, prioritize, and resolve opportunities across different line
MDRX Ratings Summary
MDRX Quant Ranking